Sign in

CIK 0001006281

  • Non-accelerated filer
  • Smaller reporting company

Protalix BioTherapeutics, Inc.

Sign in to watch
Ticker
PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
650643773
Phone
+1 201-696-9345
Business address
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
Former names
ORTHODONTIX INC, EMBASSY ACQUISITION CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-03 Bar-Shalev Amos Director Grant or award · Stock Options (Right to Buy) +17,000 17,000
2026-09-03 Bar-Shalev Amos Director Grant or award · Restricted Stock Units +8,500 8,500
2025-11-18 Bar-Shalev Amos Director Sale −168 $1.87 $314 0
2025-09-03 Bar-Shalev Amos Director Grant or award +7,500 7,500
2025-09-03 Bar-Shalev Amos Director Grant or award · Stock Options (Right to Buy) +15,000 15,000
2023-09-29 Bar-Shalev Amos Director Grant or award · Stock Options (Right to Buy) +61,676 61,676
2022-09-07 Bar-Shalev Amos Director Grant or award · Stock Options (Right to Buy) +50,000 50,000
2020-01-20 Bar-Shalev Amos Director Grant or award · Stock Options (Right to Buy) +40,000 40,000
2009-12-02 Bar-Shalev Amos Director Purchase +1,000 $8.68 $9K 1,000
2009-12-02 Bar-Shalev Amos Director Purchase +680 $8.20 $6K 1,680
2006-12-31 Bar-Shalev Amos Director Grant or award +6,186,046 6,186,046

Page 1 of 1 · 11 trades